Cigna Group
XMUN:CGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cigna Group
XMUN:CGN
|
US |
|
C
|
Clicks Group Ltd
XBER:N1C
|
ZA |
|
Mitsubishi Electric Corp
TSE:6503
|
JP |
|
B
|
British American Tobacco PLC
DUS:BMT
|
UK |
|
M
|
Mitsubishi UFJ Financial Group Inc
F:MFZ
|
JP |
|
A
|
AxoGen Inc
XBER:LT3
|
US |
|
Banco Bilbao Vizcaya Argentaria SA
MAD:BBVA
|
ES |
|
B
|
Budweiser Brewing Company APAC Ltd
OTC:BDWBF
|
HK |
|
A
|
Airtel Africa PLC
XBER:9AA
|
UK |
|
W
|
WhiteHorse Finance Inc
F:M9X
|
US |
|
China Merchants Port Holdings Co Ltd
OTC:CMHHY
|
HK |
|
R
|
RWE AG
XBER:RWE
|
DE |
Cigna Group
Cigna Group, a recognized titan in the health services landscape, traces its origins to 1792 when it began as the Insurance Company of North America (INA). This rich history speaks volumes about its deep-rooted expertise and robust resilience in an ever-evolving industry. Today, Cigna operates as a global health services powerhouse, deriving its core revenues from an intricate blend of health insurance products and services targeted towards employers, individuals, and government entities. The company's ability to seamlessly fuse traditional insurance models with innovative health solutions highlights its commitment to improving patient outcomes. Cigna's operational model is anchored on its extensive provider network, supplemented by a suite of digital health tools aimed at enhancing customer engagement. This hybrid approach not only simplifies access to medical care but also reinforces its strategic focus on affordability and personalized health journeys for its clients. Financially, Cigna's success is a byproduct of its diversified revenue streams, encompassing global health care, international markets, and supplemental health benefits. At its core, Cigna makes money through premium collections, investment income, and administrative fees from managing prescription drug plans and health services. With the acquisition of Express Scripts in 2018, Cigna prominently positioned itself in the pharmacy benefits management sector, adding another lucrative revenue channel. This strategic maneuver has fostered vertical integration within the company, aligning its pharmacy services with its insurance offerings to manage costs more effectively. Through a relentless pursuit of operational efficiency and strategic expansion, Cigna continues to leverage its scale and diversified offerings, remaining a key player in delivering accessible and cost-effective health care solutions worldwide.
Cigna Group, a recognized titan in the health services landscape, traces its origins to 1792 when it began as the Insurance Company of North America (INA). This rich history speaks volumes about its deep-rooted expertise and robust resilience in an ever-evolving industry. Today, Cigna operates as a global health services powerhouse, deriving its core revenues from an intricate blend of health insurance products and services targeted towards employers, individuals, and government entities. The company's ability to seamlessly fuse traditional insurance models with innovative health solutions highlights its commitment to improving patient outcomes. Cigna's operational model is anchored on its extensive provider network, supplemented by a suite of digital health tools aimed at enhancing customer engagement. This hybrid approach not only simplifies access to medical care but also reinforces its strategic focus on affordability and personalized health journeys for its clients.
Financially, Cigna's success is a byproduct of its diversified revenue streams, encompassing global health care, international markets, and supplemental health benefits. At its core, Cigna makes money through premium collections, investment income, and administrative fees from managing prescription drug plans and health services. With the acquisition of Express Scripts in 2018, Cigna prominently positioned itself in the pharmacy benefits management sector, adding another lucrative revenue channel. This strategic maneuver has fostered vertical integration within the company, aligning its pharmacy services with its insurance offerings to manage costs more effectively. Through a relentless pursuit of operational efficiency and strategic expansion, Cigna continues to leverage its scale and diversified offerings, remaining a key player in delivering accessible and cost-effective health care solutions worldwide.
Strong quarter: Cigna reported first-quarter revenue of $68.5 billion and adjusted EPS of $7.79, and raised full-year 2026 adjusted EPS guidance to at least $30.35.
Portfolio shift: Management announced plans to exit the individual exchange business at the end of 2026 and to begin a strategic review of alternatives for eviCore.
Specialty strength: Evernorth’s Specialty and Care Services posted 20% earnings growth, helped by specialty drug demand, biosimilars, specialty generics and the Shields investment.
PBM transition: Pharmacy Benefit Services was in line with expectations as Cigna continues to build toward its new rebate-free [Signature] model, which will become the standard model in 2028.
Cigna Healthcare: Earnings beat expectations and grew 18% year over year, with a 79.8% medical care ratio helped by lower flu, weather-related deferrals and mix.
Leadership change: David Cordani will move to Executive Chair on July 1, and Brian Evanko will become CEO, with continued emphasis on AI, affordability and personalization.
